Home > Insider Trading > Filing (0001209191-11-022220)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1411861	Mako Surgical Corp.	MAKO	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	201901148

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1424202	Morry S Blumenfeld	2555 Davie Road Fort Lauderdale FL 33317		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-04-07	11,846	$26.25	639,057	No	4	S	Indirect	By Ziegler Meditech Equity Partners, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Ziegler Meditech Equity Partners, L.P.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	72,147	Indirect	By Meditech Advisors LLC

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ziegler Meditech Equity Partners, L.P. on March 4, 2011.
The price in Column 4 is a weighted average price per share. The shares were sold in multiple transasctions at prices ranging from $26.22 per share to $26.26 per share. The reporting person will provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
The reporting person is a member of the board of managers of Ziegler Meditech Partners, LLC, the general partner of Ziegler Meditech Equity Partners, L.P., but he disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
The shares are held by Meditech Advisors LLC in trust for its partners. The partners of Meditech Advisors are Eitan Machover, Samuel Cubac, Grosvenor LLC and Allandale Ltd. The reporting person and certain of his family members constitute the members of Grosvenor LLC. As such, the reporting person may be deemed to be an indirect beneficial owner of these shares, but he disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.